It is true that many Americans legally purchase medications from licensed Canadian pharmacies that follow strict safety and prescription verification processes
The earlier SUSTAIN dose-finding studies for diabetes (Nauck et al., Diabetes Care, 2016) tested multiple dose levels including 0.05 mg, 0.1 mg, 0.2 mg, 0.3 mg, and 0.4 mg daily (note: daily, not weekly) of oral semaglutide and found dose-dependent reductions in HbA1c and body weight at every dose tested
Most side effects are mild and tend to improve as the body adjusts over several weeks
They also slow gastric emptying, prolonging the feeling of fullness after meals and reducing overall caloric consumption
In select situations, preoperative GLP-1-RA discontinuation may be considered, with the caveat that it may result in perioperative hyperglycemia